ストックスクリーナーアプリを入手
59.20
1.58%
0.8772
前日終値:
$58.32
開ける：
$58.62
24時間の取引高:
476.50K
Relative Volume:
0.51
時価総額：
$3.01B
収益：
$534.53M
当期純損益:
$-11.45M
株価収益率:
-245.53
EPS:
-0.2411
ネットキャッシュフロー:
$48.28M
1週間 パフォーマンス:
+5.37%
1か月 パフォーマンス:
+20.95%
6か月 パフォーマンス:
+103.05%
1年 パフォーマンス:
+57.89%
1日の値動き範囲:
$57.94
$59.69
1週間の範囲:
$55.66
$59.88
52週間の値動き範囲:
$25.36
$59.88
Atricure Inc Stock (ATRC) Company Profile
Compare ATRC vs ISRG, BDX, RMD, ALC, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
59.26 | 2.77B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
400.64 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
182.88 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
224.54 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
65.44 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.18 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-18 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2026-02-11 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-12-17 | 再開されました | JP Morgan | Overweight |
| 2024-04-23 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-29 | 開始されました | UBS | Buy |
| 2021-08-05 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 繰り返されました | Needham | Buy |
| 2020-11-06 | 繰り返されました | Needham | Buy |
| 2020-04-07 | 開始されました | Oppenheimer | Outperform |
| 2020-02-06 | 開始されました | BTIG Research | Buy |
| 2020-01-24 | 繰り返されました | Needham | Buy |
| 2019-08-13 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 開始されました | JP Morgan | Overweight |
| 2018-10-04 | 繰り返されました | Needham | Buy |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-08-02 | 繰り返されました | Stifel | Buy |
| 2018-06-18 | 繰り返されました | Needham | Buy |
| 2018-04-27 | 繰り返されました | Needham | Buy |
| 2018-01-16 | 繰り返されました | Needham | Buy |
| 2017-11-02 | 繰り返されました | Needham | Buy |
| 2017-07-28 | 繰り返されました | Needham | Buy |
| 2017-05-30 | 再開されました | Piper Jaffray | Overweight |
| 2016-06-30 | 再開されました | JMP Securities | Mkt Outperform |
| 2015-10-28 | 繰り返されました | Needham | Buy |
| 2015-10-06 | 繰り返されました | Canaccord Genuity | Buy |
| 2015-10-06 | 繰り返されました | Needham | Buy |
すべてを表示
Atricure Inc (ATRC) 最新ニュース
AtriCure Executive Stock Sale Analysis - Intellectia AI
AtriCure CTO Sells 3,657 Shares - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Nigeria
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 3,657 Shares - GuruFocus
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares - investing.com
AtriCure (ATRC) CTO discloses pre-set stock sale - Stock Titan
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
How Atricure Inc. (ATRC) Affects Rotational Strategy Timing - Stock Traders Daily
AtriCure (ATRC) Momentum Meets A Pricey Narrative On $47 Fair Value - simplywall.st
AtriCure CTO Privitera Sells 7,763 Shares at $52.50 Each (NASDAQ: ATRC) - Kalkine Media
AtriCure at Wells Fargo conference: growth and margins run ahead By Investing.com - Investing.com India
AtriCure CTO Salvatore Privitera Sells 7,763 Shares via 10b5-1 Trading Plan - Kalkine Media
Atricure CTO Salvatore Privitera sells $407,557 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Chief Technical Officer Salvatore Privitera Sells 7,763 Shares - GuruFocus
Atricure CTO Salvatore Privitera sells $407,557 in stock - Investing.com
Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing - marketscreener.com
AtriCure (ATRC) CTO sells stock under preset plan - Stock Titan
Biotech Stocks At 52-Week HighsATTO, HALO, IKT, TVTX, ATRC - RTTNews
A Look at AtriCure Inc (ATRC) After 7.5% Gain -- GF Value $39.67 vs Price $52.59 - GuruFocus
ATRC Maintains by Needham -- Price Target Raised to $64.00 - GuruFocus
AtriCure Price Target Raised to $64.00/Share From $45.00 by Needham - Moomoo
Atricure stock hits 52-week high at $50.00 By Investing.com - Investing.com Nigeria
Atricure stock hits 52-week high at $50.00 - Investing.com
Needham raises AtriCure stock price target on trial outlook - Investing.com
Needham raises AtriCure stock price target on trial outlook By Investing.com - Investing.com Nigeria
AtriCure Inc. (ATRC) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
AtriCure (ATRC) Slips 1.48% to $48.54 as Shares Navigate Key Trading RangeVolatility Skew - vinanet.vn
AtriCure Inc. (ATRC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Atrial Fibrillation Surgery Market Companies, Size & Trends 2026-2035 - Precedence Research
ATRC Maintained Overweight by Piper Sandler -- Price Target Rais - GuruFocus
Piper Sandler raises AtriCure stock price target on quality measure By Investing.com - Investing.com Nigeria
Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $60 - moomoo.com
AtriCure chief legal officer sells $458,099 in stock By Investing.com - Investing.com Nigeria
Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing - marketscreener.com
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic - Yahoo Finance
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference - Yahoo Finance
BTIG raises AtriCure stock price target on new quality metric By Investing.com - Investing.com Canada
BTIG raises AtriCure stock price target on new quality metric - Investing.com
AtriCure (ATRC) Financial Results: Profit Per Share Clears Its Benchmark in the Latest Session - vinanet.vn
A Look at AtriCure Inc (ATRC) After 3.0% Gain -- GF Value $39.53 vs Price $48.98 - GuruFocus
AtriCure stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Nigeria
AtriCure stock hits 52-week high at 48.47 USD - Investing.com
AtriCure Stock: Promising Cardiovascular Surgical Platform (NASDAQ:ATRC) - Seeking Alpha
Advisors Capital Management LLC Takes Position in AtriCure, Inc. $ATRC - MarketBeat
Atricure Inc (ATRC) 財務データ
収益
当期純利益
現金流量
EPS
3.86%
大文字化:
|
ボリューム (24 時間):